Mato Hoces JA, Gonzalez Arias A. Fuentes secundarias en información de medicamentos. Pharmaklinik 1988;2(6):319-27. Pagés Jiménez MT, González Arias A. Fuentes terciarias de información de medicamentos, una ayuda para su selección. Pharmaklinik 1988;2(4):192-200. Haynes RB, Mc Kibban KA, Fitzgerald D, et al. How to keep up with the medical literature?: Why try to keep up and how to get started? Ann Intern Med 1986;105:149-53. Covell DG, Uman GC, Manning PR. Academic and clinic information needs in office practice are they being met? Ann Intern Med 1985;103:596-9. Bosso JA. Academic pharmacy practice and research DICP. Ann Pharmacother 1991;25(10):1129-31. Karchmer M. Programas de farmacovigilancia: una necesidad. Perinatol Reprod Human 1991;5(3):105-6. Investigación del uso de los medicamentos. Boletín de Medicamentos Esenciales 1993;14:1. Ruskin A. Survey of drug information needs and problems associated with communications directed to practicing physicians: Part I: physician information survey). Silver Spring, Maryland: FDA Bureau of Drugs (FDA 72-301) Applied management Science, 1974. Herman CM, Dodowskas CA. Communicating drug information to physicians. J Med Educ 1976;51:189-90. Perry CA. Online information retrieval in pharmacy and related fields. Am J Hosp Pharm 1986;43(6):1509-24. Gunnar A, Birgilta O, Folke S. Problem-oriented drug information: a clinical pharmacological service. Lancet 1983;2:1410-2. Hernández de la Figuera A. Análisis de la información pasiva de medicamentos desarrollada en un CIM hospitalario. Pharmaklinik 1990;4(1):8-12. Mailhot C, Giacona-Dahl NS. Drug information services in Quebec: determination of community and hospital pharmacists needs. DICP 1987;21(1):57-63. Candace J, Smith L, Sylna M. External quality assurance committe for drug information services. Am J Hosp Pharm 1990;47(4):87-91. Vaissère J, Creniers F. Auriche M, Juillet Y. Organisation comparée de la pharmacovigilance en France et dans 7 pays européens. Therapie 1986;41(5):369-74. Nelson RC. Drug safety, pharmacoepidemiology and regulatory decision making DICP. 1988;22(4):336-44. Control y evaluación de los efectos secundarios de los medicamentos [Informe del grupo de trabajo del CIOMS]. Ginebra: OMS, 1986. Mignot G, Chichmaman RM, Spreux A, Bernard G. Vers l'analyse coût/bénéfice d'un centre régional de pharmacovigilance. Thér J Pharmacol Clin Thér 1988;43(5):377-8.